Report Highlights
The global patient monitoring devices market should reach $42.7 billion by 2022 and more than $65.4 billion by 2027, with a compound annual growth rate (CAGR) of 8.9% during the forecast period of 2022-2027.
Report Includes
- 54 data tables and 24 additional tables
- A comprehensive overview of the global market for patient monitoring devices within the healthcare industry
- Estimation of the market size and analyses of market trends, with data from 2020, 2021, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
- Highlights of the market potential for patient monitoring devices by product types, device categories and end users
- Identification of market drivers, restraints and other forces impacting the global market and evaluation of current market size and forecast, and assessment of new developments in the industry
- Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies and a relevant patent analysis
- Company profiles of major players within the industry, including Abbott Laboratories, Bayer Healthcare AG, GE Healthcare, Medtronic and Philips Healthcare
Report Scope
This report covers a range of products, some are disease specific and others are used for all types of patients and in general for health management. The patient monitoring device market referred to in this report is limited to the devices/products included in this report. Each product market covered in this report is unique and has a different set of market dynamics and competitive landscape. The product lifecycle of each product segment also varies.
The study will enable the audience to understand and gain insights on the current market and will forecast the changing market scenario. The data provided can help users understand which market segments among device connectivity, product type and end users are expected to grow at higher rates: factors driving growth, factors limiting the growth, key opportunity areas and so on.
Discussion and analysis cover the following market factors:
• Key market analysis.
• Market dynamics (drivers and restraints)
• Market forecast period of 2022-2027.
• Competitive developments and landscape.
• Geographic regional analysis.
• Patents.
• Profiles of key market players.
The report also covers a detailed competitive outlook, including market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Abbott Laboratories, GE Healthcare, Philips Healthcare, Nihon Kohden, Omron Healthcare, Roche Diagnostics Ltd., Cardiocom, Covidien, CR Bard, Honeywell Med, Infinium Medical and InTechnology etc.
Report Synopsis
Report Metrics | Details | ||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Base year considered | 2021 | ||||||||||||||||||||||||||||||||||||||||||
Forecast period considered | 2022–2027 | ||||||||||||||||||||||||||||||||||||||||||
Base year market size | $39.5 billion | ||||||||||||||||||||||||||||||||||||||||||
Market size forecast | $65.4 billion | ||||||||||||||||||||||||||||||||||||||||||
Growth rate | CAGR of 8.9% from 2022 to 2027 | ||||||||||||||||||||||||||||||||||||||||||
Units considered | $ Millions | ||||||||||||||||||||||||||||||||||||||||||
Segments covered | Region, Product Type, Equipment/Device Category, Device Connectivity, End User | ||||||||||||||||||||||||||||||||||||||||||
Regions covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) | ||||||||||||||||||||||||||||||||||||||||||
Countries covered | U.S., Canada., Germany., U.K., France., Italy., Spain., Rest of Europe., China., Japan., India., South Korea, Rest of Asia-Pacific. | ||||||||||||||||||||||||||||||||||||||||||
Key Market Drivers |
|
||||||||||||||||||||||||||||||||||||||||||
Companies studied |
|
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
- Siemens: 360° Company Analysis (IFT322A)
- Thermo Fisher Scientific Inc.: 360° Company Analysis (HLC309A)
- Needle-Free Devices: Technologies and Global Markets (HLC178C)
- Koninklijke Philips N.V.: 360° Company Analysis (HLC308A)
- Global High Purity Quartz Market (CHM191A)
Related Reports
Global Implantable Remote Patient Monitoring Devices Market
The global market for implantable remote patient monitoring (IRPM) devices was valued at $6.5 billion in 2023. The market is expected to grow from $7.6 billion in 2024 to $20.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 21.7% from 2024 to 2029.
2024 Medical Devices Research Review
The medical device industry is a multi-billion-dollar industry whose outlook is supposed to rise in the coming years These devices treat and diagnose a multitude of patient conditions and work much better than drugs.
Global Injectable Drug Delivery Devices Market
The global market for injectable drug delivery device is estimated to increase from $216.5 billion in 2024 to reach $317.2 billion by 2029, at a compound annual growth rate (CAGR) of 7.9% from 2024 through 2029.
OTC Drugs, Medical Devices and Diagnostics: Global Markets
The global market for OTC drugs, medical devices, and diagnostics is estimated to increase from $251.7 billion in 2024 to reach $359.7 billion by 2029, at a compound annual growth rate (CAGR) of 7.4% from 2024 through 2029.
Track the Latest Global Tariff Developments
In today's fast-paced global economy, tariffs are no longer static—they are dynamic levers shaped by geopolitical realignments, supply chain vulnerabilities, inflationary pressures, and sustainability-driven trade reforms. As governments worldwide recalibrate their trade strategies, businesses are left to navigate a maze of shifting rules, rising costs, and regulatory uncertainty.
Our analysis empowers you with real-time updates and in-depth expert analysis on all facets of global tariff activity. From new trade agreements and sanctions to abrupt tariff hikes and retaliatory duties, we monitor developments across borders, sectors, and industries—so you don't have to.
Whether it's the ongoing U.S.–China trade dynamics, the evolving EU Carbon Border Adjustment Mechanism (CBAM), or the emerging policies in India, ASEAN, and Latin America, we provide full-spectrum coverage. We also track multilateral trade negotiations, World Trade Organization (WTO) rulings, and sector-specific duty structures—ensuring you are always ahead of global trade shifts.
With our analysis, you can stay informed, identify risks, and confidently respond to tariff changes—no matter where you operate.
Ready to see what tariff means for your business?
Consult with our experts or request your custom Tariff Impact Brife today
Stay Informed, Stay Competitive
In today's interconnected and unpredictable global economy, staying ahead of tariff shifts is not just important—it's essential. BCC Research provides decision-makers with trusted, research-driven insights that turn uncertainty into opportunity.
Our in-depth market analysis and trade intelligence help you decode how tariff changes impact your specific sector—manufacturing, healthcare, technology, agriculture, or energy. We break down complex data into actionable knowledge through comprehensive reports, expert commentaries, and sector-focused forecasts.
Our analysis includes:
- Thorough breakdowns of current and proposed tariff policies and how they affect regional and global trade flows.
- Sector-specific implications, helping you understand the strategic impact on sourcing, pricing, and competitiveness.
- Forward-looking insights to support risk management, planning, and response strategies for evolving trade conditions.
With BCC Research, you gain more than just information—you gain clarity and confidence to make well-informed decisions in a volatile trade environment.
Don't let tariffs catch you off guard—let our insights guide your strategy.
Recent Reports
Thermo Fisher Scientific Inc.: 360° Company Analysis
This report provides a comprehensive analysis of Thermo Fisher Scientific Inc., covering key details such as key milestones/history, product offerings, technologies, major applications and end-user industries it serves.
Needle-Free Devices: Technologies and Global Markets
The global market for needle-free devices was valued at $15.5 billion in 2024 and is estimated to increase from $17.0 billion in 2025 to reach $27.7 billion by 2030, at a compound annual growth rate (CAGR) of 10.2% from 2025 through 2030.
Koninklijke Philips N.V.: 360° Company Analysis
The report discusses a 360° analysis of Koninklijke Philips N.V. It covers various aspects of Koninklijke Philips N.V., including products, business segments, history, distributors, and financial and strategic development.
Global Thyroid Gland Disorders: Diagnostics and Treatment Market
The global market for diagnostics and treatment of thyroid gland disorders was valued at $15.5 billion in 2024 and is estimated to increase from $16.3 billion in 2025 to reach $21.0 billion by 2030, at a compound annual growth rate (CAGR) of 5.2% from 2025 through 2030.
Global Outpatient Clinics Market
The global outpatient clinics market is expected to grow from $4.4 trillion in 2024 and is projected to reach $6.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 7.6% during the forecast period of 2024 to 2029.
Top Trending Reports
Next-Generation Advanced Batteries: Global Markets
The global market for next-generation advanced batteries is estimated to grow from $1.5 billion in 2024 to reach $5.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 28.5% from 2024 through 2029.
Global Pharmaceutical Drugs Industry: Competitive Landscape 2023
This report discusses the global pharmaceutical drugs industry and its competitive landscape in terms of significant player market ranking and top pharmaceutical drugs. Company profiles of the top 50 pharmaceutical companies, innovative products and technologies, trends and market dynamics, competitive intelligence, and regional trends are well-researched and analyzed in this report.
Global Markets and Manufacturing Technologies for Protein Drugs
The global protein drugs market is expected to grow from $441.7 billion in 2024 and is projected to reach $655.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.2% during the forecast period of 2024 to 2029.
Biologic Therapeutic Drugs: Technologies and Global Markets
The global market for biologic therapeutic drugs is estimated to increase from $499.2 billion in 2024 to reach $794.5 billion by 2029, at a compound annual growth rate (CAGR) of 9.7% from 2024 through 2029.
Global Markets for Emerging Medical Device Technologies
The global market for emerging medical devices is estimated to increase from $136.6 billion in 2024 to reach $223.9 billion by 2029, at a compound annual growth rate (CAGR) of 10.4% from 2024 through 2029.
Report Highlights
The global market for patient monitoring device will grow from $20.3 billion in 2018 to $25.9 billion by 2023 at a compound annual growth rate (CAGR) of 5.0% for the period of 2018-2023.
Report Includes
- 45 data tables and 35 additional tables
- A comprehensive overview of the global market for patient monitoring devices within the healthcare industry
- Country specific data and analysis for United States, Canada, France, Germany, U.K., Spain, China, India, Japan, Middle East and Africa
- Market breakdown for patient monitoring devices by product types, device categories and end users
- Elaboration on the influence of government regulations, technological updates, and the economic factors that affect the growth of the market
- Analyses of the global market trends, strategies, and recommendations in providing the quantitative assessment of the market that can help manufacturers and suppliers understand the growth potential of different market segments
- Company profiles of major players in the market, including Abbott Laboratories, Bayer Healthcare AG, Cardiac Science Corp., Edwards Lifesciences Corp., GE Healthcare, Honeywell International Inc., Medtronic, Omron Corp., Philips Healthcare, Roche Diagnostics, and Siemens Healthcare Inc.
Report Highlights
The global patient monitoring device market reached $15.9 billion and $16.9 billion in 2014 and 2015 respectively. The market should reach $23.8 billion in 2020, increasing at a compound annual growth rate (CAGR) of 7.1% from 2015 to 2020.
Report Includes
- An overview of the global market for patient monitoring devices, accessories, and consumables that are used to measure, display, and document physiological information obtained at regular intervals over time from sensors attached to the patient or other input devices.
- Analyses of global market trends, with data from 2014, 2015, and projections of compound annual growth rates (CAGRs) through 2020.
- Examination of the market for patient monitoring devices and related equipment by application (e.g., intensive care, neonatal/pediatric care), product type (central monitoring stations, portable bedside monitors, wireless/telemetry monitors), and target markets (hospitals, long-term care facilities, and individual consumers).
- Discussion of promising new technologies and products still in the development and testing stages that are likely to be commercialized successfully in the next five years.
- Profiles of major players in the industry.
Report Highlights
The global patient monitoring device (PMD) market is expected to grow from nearly $14.7 billion in 2013 to reach nearly $21.0 billion in 2018, a compound annual growth rate (CAGR) of 7.4% for the period of 2013 to 2018.
Report Includes
- An overview of the global market for patient monitoring devices, accessories, and consumables that are used to measure, display, and document physiological information obtained at regular intervals over time from sensors attached to the patient or other input devices.
- Analyses of global market trends, with data from 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018.
- Examination of the market for patient monitoring devices and related equipment by application (e.g., intensive care, neonatal/pediatric care), product type (central monitoring stations, portable bedside monitors, wireless/telemetry monitors), and target markets (hospitals, long-term care facilities, and individual consumers).
- Discussion of promising new technologies and products still in the development and testing stages that are likely to be commercialized successfully in the next five years.
- Comprehensive company profiles of major players in the industry.
Report Highlights
- The U.S. market for patient monitoring devices, accessories, and consumables was worth nearly $6.2 billion in 2007. The market is projected to grow to almost $6.5 billion in 2008 and $8.6 billion by 2013, representing a compound annual growth rate (CAGR) of 5.7%.
- The monitoring devices segment has the largest share of the market, worth $3.6 billion in 2007 and an estimated $3.8 billion in 2008. This is expected to grow at a CAGR of 6.2% to reach $5.1 billion in 2013.
- Disposable sensors and other consumables generated $2.6 billion in 2007. This should increase to $2.7 billion in 2008 and $3.4 billion in 2013, for a CAGR of 5.1%.
Report Highlights
-
The U.S. market for patient monitoring devices and related consumable supplies such as disposable sensors was worth an estimated $4.3 billion in 2005. The market is projected to grow to $4.6 billion in 2006 and $6.3 billion by 2011, an AAGR of 6.7%.
-
The home-care market has the highest projected growth rate of any market segment (i.e., an average of 13.8% between 2006-2011). Other segments with relatively high growth rates include progressive care/cardio-pulmonary rehabilitation (4.8%) and long term/non-acute care (4.0%).
-
Across the market, there has been a noticeable trend away from bedside and tabletop monitors, towards hand-held and wearable monitors. With a projected growth rate of 12.8%, the market for hand-held and wearable monitors is expected to grow from $1 billion in 2005 (46% of the market, excluding consumables) to over $2 billion (59%) in 2011.
Report Highlights
-
The U.S. market will rise to $4.3 billion by 2008, at an average annual growth rate (AAGR) of 8.1%.
-
The home care market has the highest growth rate of any market segment.
-
Averaging 11.7%/year, the handheld monitor market will reach $1.6 billion in 2008.
-
The phone or wireless telemetry monitor market will reach $405 million in 2008.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More